Takeda Pharmaceutical Co Ltd (TKPHF) stock
TKPHFOTCPharmaceutical PreparationsAlso trades as TAK
$39.00+0.36 (+0.93%)
Close on Oct 19, 2026Market cap $134.41BP/E –Yield –
Takeda Pharmaceutical enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Takeda Pharmaceutical's enterprise value was $89.49B on Oct 19, 2026, against $69.58B a year earlier. Over the last 5 years it ranged from $65.20B to $89.49B, with a median of $74.87B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $89.49B | +17.8% |
| 2025 | Dec 31, 2025 | $75.95B | +8.8% |
| 2024 | Dec 31, 2024 | $69.78B | -3.7% |
| 2023 | Dec 29, 2023 | $72.47B | -4.5% |
| 2022 | Dec 30, 2022 | $75.89B | +1.4% |
| 2021 | Dec 31, 2021 | $74.87B | -25.6% |
| 2020 | Dec 31, 2020 | $100.60B | -7.1% |
| 2019 | Dec 31, 2019 | $108.25B | +225.9% |
| 2018 | Dec 31, 2018 | $33.22B | -21.2% |
| 2017 | Dec 29, 2017 | $42.15B | – |